Cargando…

Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption

Genetic defects in a number of components of the dystrophin–glycoprotein complex (DGC) lead to distinct forms of muscular dystrophy. However, little is known about how alterations in the DGC are manifested in the pathophysiology present in dystrophic muscle tissue. One hypothesis is that the DGC pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Straub, Volker, Rafael, Jill A., Chamberlain, Jeffrey S., Campbell, Kevin P.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1997
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139791/ https://www.ncbi.nlm.nih.gov/pubmed/9334342

Ejemplares similares

Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy
Publicado: (1996)

Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury
por: Quattrocelli, Mattia, et al.
Publicado: (2017)

An update on Becker muscular dystrophy
por: Straub, Volker, et al.
Publicado: (2023)

Reduced Sarcolemmal Membrane Repair Exacerbates Striated Muscle Pathology in a Mouse Model of Duchenne Muscular Dystrophy
por: Paleo, Brian J., et al.
Publicado: (2022)

A high–throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies
por: Scaglioni, Dominic, et al.
Publicado: (2020)

The Classification, Natural History and Treatment of the Limb Girdle Muscular Dystrophies
por: Murphy, Alexander Peter, et al.
Publicado: (2015)

Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human Trials
por: Wang, Zejing, et al.
Publicado: (2011)

δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches
por: Blain, Alison M, et al.
Publicado: (2011)

Quantifying the burden of caregiving in Duchenne muscular dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2016)

Compliance to Care Guidelines for Duchenne Muscular Dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2015)

Muscular Dystrophy Meets the Gene Chip: New Insights into Disease Pathogenesis
por: Chamberlain, Jeffrey S.
Publicado: (2000)

Resting-state functional MRI shows altered default-mode network functional connectivity in Duchenne muscular dystrophy patients
por: Doorenweerd, Nathalie, et al.
Publicado: (2021)

Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies
por: Suriyonplengsaeng, Chinnawut, et al.
Publicado: (2017)

Gene therapy in Duchenne muscular dystrophy: Identifying and preparing for the challenges ahead
por: Heslop, Emma, et al.
Publicado: (2021)

Measurement of salivary testosterone in adolescents and young men with Duchenne muscular dystrophy
por: Sahun, Yolanda Alins, et al.
Publicado: (2021)

Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice
por: Duclos, Franck, et al.
Publicado: (1998)

The burden of Duchenne muscular dystrophy: An international, cross-sectional study
por: Landfeldt, Erik, et al.
Publicado: (2014)

Cellular and animal models for facioscapulohumeral muscular dystrophy
por: DeSimone, Alec M., et al.
Publicado: (2020)

Improving recognition of Duchenne muscular dystrophy: a retrospective case note review
por: van Ruiten, Henriette J A, et al.
Publicado: (2014)

Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
por: Kang, Peter B., et al.
Publicado: (2023)

Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis
por: Landfeldt, Erik, et al.
Publicado: (2016)

Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy
por: Sciandra, Francesca, et al.
Publicado: (2015)

CRISPR-Generated Animal Models of Duchenne Muscular Dystrophy
por: Lim, Kenji Rowel Q., et al.
Publicado: (2020)

New aspects on patients affected by dysferlin deficient muscular dystrophy
por: Klinge, Lars, et al.
Publicado: (2009)

Sarcoglycan Complex: IMPLICATIONS FOR METABOLIC DEFECTS IN MUSCULAR DYSTROPHIES
por: Groh, Séverine, et al.
Publicado: (2009)

Beta-Blockers, Left and Right Ventricular Function, and In-Vivo Calcium Influx in Muscular Dystrophy Cardiomyopathy
por: Blain, Alison, et al.
Publicado: (2013)

Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model
por: Howard, Zachary M., et al.
Publicado: (2021)

Elevation of fast but not slow troponin I in the circulation of patients with Becker and Duchenne muscular dystrophy
por: Barthel, Benjamin L., et al.
Publicado: (2021)

Prevalence of Pain within Limb Girdle Muscular Dystrophy R9 and Implications for Other Degenerative Diseases
por: Richardson, Mark, et al.
Publicado: (2021)

Letter to the Editor: In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
por: Muntoni, Francesco, et al.
Publicado: (2023)

Tracking progress: an update on animal models for Duchenne muscular dystrophy
por: Wells, Dominic J.
Publicado: (2018)

Muscular dystrophy: Experimental animal models and therapeutic approaches (Review)
por: Gaina, Gisela, et al.
Publicado: (2021)

Is ongoing testosterone required after pubertal induction in Duchenne muscular dystrophy?
por: Wood, Claire L, et al.
Publicado: (2023)

Disruption of sarcolemmal dystrophin and β-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis
por: Celes, MR, et al.
Publicado: (2010)

Sarcolemmal-restricted localization of functional ClC-1 channels in mouse skeletal muscle
por: Lueck, John D., et al.
Publicado: (2010)

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
por: Frank, Diane E., et al.
Publicado: (2020)

Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy
por: Zaharieva, Irina T., et al.
Publicado: (2013)

Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy
por: Chiu, Yen-Hui, et al.
Publicado: (2009)

Identification of Muscle-Specific MicroRNAs in Serum of Muscular Dystrophy Animal Models: Promising Novel Blood-Based Markers for Muscular Dystrophy
por: Mizuno, Hideya, et al.
Publicado: (2011)

Growth pattern trajectories in boys with Duchenne muscular dystrophy
por: Stimpson, Georgia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_thcrpcui2l4k2imt3m0anpf0it